High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaci.2013.02.047PMID 23726261
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical picture of heparin-induced thrombocytopenia

  2012cited by this paper
• Heparin-induced skin lesions.

  2012cited by this paper
• Fondaparinux - data on efficacy and safety in special situations.

  2012cited by this paper
• VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

  2012influential reference
• Evidence-Based Clinical Practice Guidelines ed: American College of Chest Physicians Therapy and Prevention of Thrombosis, 9th Therapy, and Pregnancy : Antithrombotic VTE, Thrombophilia, Antithrombotic

  2012cited by this paper
• Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.

  2010cited by this paper
• Heparin-induced skin lesions

  2010cited by this paper
• Heparin‐induced non‐necrotizing skin lesions: rarely associated with heparin‐induced thrombocytopenia

  2010cited by this paper
• Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4.

  2010cited by this paper
• Low allergenic potential with fondaparinux: results of a prospective investigation.

  2010cited by this paper
• Diagnosis of heparin-induced delayed type hypersensitivity

  2010cited by this paper
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients

  2010cited by this paper
• Systemic Reduction of Functionally Suppressive CD4dimCD25highFoxp3+ Tregs in Human Second Trimester Pregnancy Is Induced by Progesterone and 17β-Estradiol1

  2009cited by this paper
• Incidence and causes of heparin-induced skin lesions

  2009cited by this paper
• Successful Heparin Desensitization: A Case Report and Review of the Literature

  2008cited by this paper
• Danaparoid in der Schwangerschaft bei Heparinunverträglichkeit

  2007cited by this paper
• [Danaparoid in pregnancy in cases of heparin intolerance - use in 59 cases].

  2007cited by this paper
• Allergy to heparins and anticoagulants with a similar pharmacological profile: an update

  2006cited by this paper
• Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings

  2006cited by this paper
• Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases.

  2006cited by this paper
• Low‐molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor‐κB in LPS‐stimulated human monocytes

  2006cited by this paper
• Use of low-molecular-weight heparin from the first trimester of pregnancy: a retrospective study of 111 consecutive pregnancies.

  2006cited by this paper
• Heparin-induced thrombocytopenia.

  2006cited by this paper
• Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux

  2006cited by this paper
• Management of cutaneous type IV hypersensitivity reactions induced by heparin

  2006cited by this paper
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients

  2005cited by this paper
• Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergy

  2005cited by this paper
• Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study.

  2005cited by this paper
• Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides

  2005cited by this paper
• [Cutaneous necroses mainly on the extremities].

  2004cited by this paper
• Treatment of 51 pregnancies with danaparoid because of heparin intolerance

  2004cited by this paper
• Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis

  2003cited by this paper
• Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans

  2003cited by this paper
• Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations

  2003cited by this paper
• High rate of skin complications due to low‐molecular‐weight heparins in pregnant women

  2003cited by this paper
• Delayed‐Type Hypersensitivity and Cross‐Reactivity to Heparins and Danaparoid: A Prospective Study

  2001cited by this paper
• Management of heparin allergy during pregnancy with danaparoid.

  2001cited by this paper
• Heparin-induced thrombocytopenia is rare in pregnancy.

  2001cited by this paper
• Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.

  2000cited by this paper
• First Workshop for Detection of Heparin-induced Antibodies: Validation of the Heparin-induced Platelet-activation Test (HIPA) in Comparison with a PF4/Heparin ELISA

  1999cited by this paper
• Association of heparin‐induced skin lesions, intracutaneous tests, and heparin‐induced IgG

  1999cited by this paper
• Heparin-induced skin lesions.

  1998cited by this paper
• Low-molecular-weight heparins and new strategies for the treatment of patients with established venous thrombosis.

  1996cited by this paper
• Heparin‐induced skin lesions

  1996cited by this paper
• Accuracy of clinical assessment of deep-vein thrombosis.

  1995cited by this paper
• Successful heparin desensitization after heparin-induced anaphylactic shock.

  1995cited by this paper
• Rush desensitization in heparin hypersensitivity: a case report

  1994cited by this paper
• The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics

  1993cited by this paper

• When prophylaxis turns pathologic: a case of LMWH-induced necrosis with secondary cellulitis

  2025cites this paper
• Low-molecular-weight heparins utilization in pregnant and postpartum women: a real-world analysis in China (2016–2021)

  2025cites this paper
• A preventable problem in pregnancy

  2025cites this paper
• Safety and efficacy of low dose or no heparinization in cerebral angiography: A randomized controlled study (SELECT trial)

  2024cites this paper
• Diagnostik und Therapie einer VTE in der Schwangerschaft

  2023cites this paper
• Cutaneous hypersensitivity reaction to low molecular weight heparins in pregnancy, cross reactivity and prednisolone treatment: A case report

  2022cites this paper
• Localized and Generalized Skin Adverse Drug Reactions to Nadroparin Calcium Injection in 6 Cases of Pregnant Women

  2022cites this paper
• Low Molecular Weight Heparins (LMWH) and Implications along Pregnancy: a Focus on the Placenta

  2021cites this paper
• Effect of low-molecular-weight heparins on anti-Xa peak levels and adverse reactions in Chinese patients with recurrent spontaneous abortion: a single-center, observational study

  2021cites this paper
• Embarazo y COVID-19. Consideraciones en la práctica de la hematología

  2021cites this paper
• Comparison of doses of heparin for venous thromboembolism and bleeding in pregnant women

  2021cites this paper
• Atrial fibrillation during pregnancy: a 9-month period with limited options

  2021cites this paper
• Pharmacological and clinical application of heparin progress: An essential drug for modern medicine.

  2021cites this paper
• How I treat venous thromboembolism in pregnancy.

  2020cites this paper
• Progress of the ALIFE2 study: A dynamic road towards more evidence.

  2020cites this paper
• Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE—Position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)

  2020cites this paper
• Contemporary best practice in the management of pulmonary embolism during pregnancy

  2020cites this paper
• Bleeding, Heparin-induced thrombocytopenia, and Other adverse reactions

  2020cites this paper
• Everything the clinician needs to know about evidence-based anticoagulation in pregnancy.

  2019cites this paper
• Valvular heart disease during pregnancy: a clinical case and a literature review

  2019cites this paper
• Renal Replacement Therapy in Adult Patients After Cardiac Surgery.

  2019cites this paper
• How Do We Treat Pregnancy-Related Venous Thromboembolism?

  2019cites this paper
• Drug Hypersensitivity

  2018cites this paper
• Low incidence of heparin‐induced skin lesions in orthopedic surgery patients with low‐molecular‐weight heparins

  2018cites this paper
• Eosinophilia and Kidney Disease: More than Just an Incidental Finding?

  2018cites this paper
• Hypersensitivity reactions to low molecular weight heparins: different patterns of cross-reactivity in 3 patients.

  2018cites this paper
• Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA

  2018cites this paper
• Spättypreaktionen auf oral und parenteral verabreichte Arzneimittel

  2017cites this paper
• Nadroparin carries a potentially high risk of inducing cutaneous delayed‐type hypersensitivity responses

  2017cites this paper
• Delayed‐type hypersensitivity to oral and parenteral drugs

  2017cites this paper
• Hypersensitivity reactions to LMWHs: different patterns of cross-reactivity in three patients. Case series and a literature review

  2017cites this paper
• Treatment of pregnancy-associated venous thromboembolism - position paper from the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH).

  2016cites this paper
• Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre

  2016influential citation
• Hypersensitivity reactions to enoxaparin and unfractionated heparin in a pregnant woman with gestational thrombocytopenia: A case report

  2016cites this paper
• Methods for Testing Immunological Factors

  2015cites this paper
• Hypersensitivity reactions to low molecular weight heparin in a pregnant woman : : case report

  2015cites this paper
• Hypersensibilité retardée aux héparines : du diagnostic à la prise en charge

  2015cites this paper
• New studies of low-molecular-weight heparin in pregnancy.

  2015cites this paper
• The use of fondaparinux in pregnancy

  2015influential citation
• Efectos secundarios cutáneos causados por las heparinas

  2014cites this paper
• Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2013.

  2014cites this paper
• Anticoagulation in pregnancy complications.

  2014cites this paper
• Incidence of hypersensitivity skin reactions in patients on full-dose low-molecular-weight heparins during pregnancy.

  2013cites this paper
• Atrial fibrillation during pregnancy: a nine-month period with limited options

  year unknowncites this paper